All 51 GNOM (GLOBAL X GENOMICS & BIOTECHNOLOGY ETF) Holdings
There are 51 GNOM holdings. Top 10 companies weight: 42.11%.
Total Market Cap: $2.05T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (51 stocks) | +25.45% | 30.45 | 20.87 | 0.28 | +19.41% | +22.44% | 0.68 | ||||||||||
1 | ILMN | Illumina Inc | 4.57% | $162.55 | $22B | Diagnostics & Research | Healthcare | -6.57% | 34.97 | 31.15 | 2.63 | N/A | N/A | 58 | -11.52% | $144 | -16.21% | 1.03 |
2 | GH | Guardant Health Inc | 4.57% | $130.17 | $17B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 75 | +0.82% | $131 | +2.00% | 1.22 |
3 | LEGN | Legend Biotech Corp Adr | 4.46% | $36.28 | $5.26B | Biotechnology | Healthcare | -13.49% | N/A | 181.82 | N/A | N/A | N/A | 80 | +52.67% | $55 | -1.81% | 0.54 |
4 | ARWR | Arrowhead Pharmaceuticals Inc | 4.38% | $70.82 | $11B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 77 | +24.50% | $88 | -0.47% | 1.65 |
5 | VRTX | Vertex Pharmaceuticals Inc | 4.19% | $425.09 | $111B | Biotechnology | Healthcare | +9.89% | 25.66 | 23.04 | 1.64 | N/A | N/A | 74 | +29.08% | $549 | +15.02% | 0.51 |
6 | PRAX | Praxis Precision Medicines Inc Ordinary Shares | 4.17% | $258.08 | $9.95B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 73 | +152.70% | $652 | -1.55% | 0.90 |
7 | NTRA | Natera Inc | 4.02% | $212.73 | $29B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +22.64% | $261 | +17.58% | 1.34 |
8 | BMRN | Biomarin Pharmaceutical Inc | 4.00% | $53.32 | $10B | Biotechnology | Healthcare | -20.33% | 37.51 | 11.05 | 0.64 | N/A | N/A | 75 | +64.76% | $88 | -7.17% | 0.70 |
9 | MRNA | Moderna Inc | 3.92% | $45.64 | $19B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 48 | -5.35% | $43 | -25.22% | 1.37 |
10 | CRSP | Crispr Therapeutics Ag | 3.83% | $52.02 | $5.16B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | N/A | N/A | N/A | -13.88% | N/A |
11 | BNTX | Biontech Se Adr | 3.53% | $89.14 | $24B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 69 | +39.17% | $124 | -15.79% | 0.95 |
12 | TWST | Twist Bioscience Corp | 3.52% | $70.15 | $3.99B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 75 | -8.14% | $64 | -6.10% | 2.04 |
13 | QGEN | Qiagen Nv | 3.45% | $35.69 | $7.46B | Diagnostics & Research | Healthcare | +3.15% | 17.55 | 11.38 | 0.04 | N/A | N/A | 65 | +22.78% | $44 | -5.24% | 0.52 |
14 | TECH | Bio-techne Corp | 3.31% | $49.77 | $7.53B | Biotechnology | Healthcare | -10.07% | 68.59 | 25.32 | 0.66 | N/A | N/A | N/A | N/A | N/A | -12.94% | N/A |
15 | VCYT | Veracyte Inc | 3.29% | $47.80 | $3.55B | Diagnostics & Research | Healthcare | N/A | 40.15 | 28.01 | 0.25 | N/A | N/A | 70 | -0.84% | $47 | +7.11% | 1.41 |
16 | BEAM | Beam Therapeutics Inc | 3.14% | $28.96 | $3.28B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +76.35% | $51 | -18.35% | 1.79 |
17 | RARE | Ultragenyx Pharmaceutical Inc | 2.67% | $21.78 | $2.30B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +138.98% | $52 | -25.42% | 1.00 |
18 | TXG | 10x Genomics Inc Ordinary Shares Class A | 2.53% | $30.71 | $3.27B | Health Information Services | Healthcare | N/A | N/A | 500.00 | N/A | N/A | N/A | 60 | -17.84% | $25 | -29.23% | 1.98 |
19 | n/a | Genscript Biotech Corp Class H | 2.24% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
20 | LLY | Eli Lilly And Co | 2.20% | $1,065.12 | $970B | Drug Manufacturers - General | Healthcare | +29.14% | 45.43 | 29.85 | 0.18 | N/A | N/A | 71 | +14.08% | $1.22K | +40.67% | 0.71 |
21 | CAI | Caris Life Sciences Inc | 2.16% | $16.52 | $4.35B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 73 | +68.46% | $28 | 0.00% | 1.49 |
22 | GILD | Gilead Sciences Inc | 2.08% | $127.57 | $166B | Drug Manufacturers - General | Healthcare | +98.59% | 18.01 | 15.22 | 0.33 | N/A | N/A | N/A | N/A | N/A | +18.23% | N/A |
23 | SRPT | Sarepta Therapeutics Inc | 2.04% | $16.25 | $1.76B | Biotechnology | Healthcare | N/A | 4.62 | 5.73 | 159.25 | N/A | N/A | 51 | +35.38% | $22 | -26.11% | 1.39 |
24 | BLLN | Billiontoone Inc Ordinary Shares Class A | 1.99% | $94.25 | $4.18B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +24.89% | $118 | 0.00% | 1.89 |
25 | AZN | Astrazeneca Plc | 1.94% | $177.46 | $290B | Drug Manufacturers - General | Healthcare | +17.09% | 27.89 | 17.67 | 0.83 | N/A | N/A | 77 | +26.50% | $224 | +12.11% | 0.40 |
26 | QURE | Uniqure Nv | 1.72% | $26.76 | $1.59B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 69 | +46.38% | $39 | -5.16% | 1.33 |
27 | NTLA | Intellia Therapeutics Inc | 1.68% | $13.13 | $1.62B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +102.82% | $27 | -28.75% | 1.70 |
28 | STOK | Stoke Therapeutics Inc | 1.62% | $28.68 | $1.96B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +57.25% | $45 | -5.78% | 1.09 |
29 | BMY | Bristol-myers Squibb Co | 1.21% | $54.46 | $117B | Drug Manufacturers - General | Healthcare | +5.08% | 13.54 | 9.06 | 183.93 | N/A | N/A | 61 | +15.83% | $63 | +0.55% | 0.26 |
30 | VIR | Vir Biotechnology Inc | 1.16% | $8.74 | $1.47B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +135.24% | $21 | -28.26% | 1.58 |
31 | WVE | Wave Life Sciences Ltd | 1.13% | $5.69 | $1.22B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +285.59% | $22 | -3.81% | 1.46 |
32 | DHR | Danaher Corp | 1.13% | $176.13 | $123B | Diagnostics & Research | Healthcare | -4.86% | 33.26 | 21.60 | 1.11 | N/A | N/A | N/A | N/A | N/A | -3.28% | N/A |
33 | WGS | Genedx Holdings Corp Ordinary Shares Class A | 1.09% | $53.13 | $1.43B | Diagnostics & Research | Healthcare | N/A | N/A | 166.67 | N/A | N/A | N/A | 77 | +44.93% | $77 | -32.76% | 1.60 |
34 | CDNA | Caredx Inc | 1.05% | $22.07 | $1.14B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | +16.90% | $26 | -22.71% | 1.31 |
35 | MRVI | Maravai Lifesciences Holdings Inc Ordinary Shares Class A | 0.52% | $4.83 | $451M | Biotechnology | Healthcare | N/A | N/A | 370.37 | N/A | N/A | N/A | 63 | +18.01% | $5.70 | -34.56% | 1.24 |
36 | RGNX | Regenxbio Inc | 0.50% | $6.52 | $345M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +270.86% | $24 | -28.40% | 1.76 |
37 | PSNL | Personalis Inc | 0.44% | $11.14 | $994M | Diagnostics & Research | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 75 | -2.51% | $11 | -11.65% | 2.15 |
38 | BNTC | Benitec Biopharma Inc | 0.41% | $10.58 | $399M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +129.96% | $24 | -33.26% | 0.78 |
39 | RCKT | Rocket Pharmaceuticals Inc | 0.40% | $2.89 | $326M | Biotechnology | Healthcare | -5.96% | N/A | N/A | N/A | N/A | N/A | 55 | +221.80% | $9.30 | -41.47% | 1.36 |
40 | MYGN | Myriad Genetics Inc | 0.38% | $4.31 | $371M | Diagnostics & Research | Healthcare | N/A | N/A | 54.05 | N/A | N/A | N/A | 50 | +45.01% | $6.25 | -30.84% | 1.13 |
41 | PACB | Pacific Biosciences Of California Inc | 0.37% | $1.58 | $401M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 56 | +55.57% | $2.46 | -42.65% | 2.02 |
42 | BRKR | Bruker Corp | 0.34% | $57.31 | $7.40B | Medical Devices | Healthcare | N/A | N/A | 15.22 | 1.52 | N/A | N/A | 69 | -12.35% | $50 | -3.20% | 1.22 |
43 | A | Agilent Technologies Inc | 0.33% | $135.02 | $33B | Diagnostics & Research | Healthcare | +11.51% | 25.45 | 22.42 | 6.50 | N/A | N/A | 75 | +19.47% | $161 | +0.50% | 0.98 |
44 | LAB | Standard Biotools Inc | 0.33% | $1.16 | $414M | Medical Devices | Healthcare | N/A | 5.37 | N/A | N/A | N/A | N/A | 58 | +33.62% | $1.55 | -21.17% | 1.56 |
45 | PRME | Prime Medicine Inc | 0.33% | $3.21 | $596M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | +115.58% | $6.92 | 0.00% | 2.10 |
46 | FLGT | Fulgent Genetics Inc | 0.33% | $18.70 | $516M | Diagnostics & Research | Healthcare | N/A | N/A | 7.70 | N/A | N/A | N/A | 62 | -1.07% | $19 | -23.48% | 0.65 |
47 | MLAB | Mesa Laboratories Inc | 0.31% | $106.66 | $502M | Scientific & Technical Instruments | Technology | N/A | 136.69 | 35.21 | N/A | N/A | N/A | 58 | +5.01% | $112 | -15.77% | 1.52 |
48 | EDIT | Editas Medicine Inc | 0.30% | $2.82 | $349M | Biotechnology | Healthcare | -10.67% | N/A | N/A | N/A | N/A | N/A | 55 | +104.96% | $5.78 | -38.99% | 2.20 |
49 | DGX | Quest Diagnostics Inc | 0.29% | $193.18 | $21B | Diagnostics & Research | Healthcare | +8.13% | 21.62 | 18.15 | 1.49 | N/A | N/A | N/A | N/A | N/A | +10.70% | N/A |
50 | CRBU | Caribou Biosciences Inc Ordinary Shares | 0.26% | $2.32 | $224M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +417.24% | $12 | 0.00% | 1.89 |
GNOM (GLOBAL X GENOMICS & BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
89.00%MATERIALS
1.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%